Sexual Health
Nearly two of every three adult Americans under age 65 who were covered by public insurance from 2005 to 2006 had at least one chronic illness, such as diabetes, heart disease, and kidney disease, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
A new study finds that nearly one in four African American women with late stage breast cancer refused chemotherapy and radiation therapy, potentially life saving therapies. Published in the July 1, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that more efforts are needed to ensure that all women with breast cancer receive appropriate care.
Dynavax Technologies Corporation (Nasdaq:DVAX) announced the award of a Small Business Innovation Research (SBIR) grant by the National Institute of Allergy and Infectious Diseases (NIAID). This grant will support the preclinical development of Dynavax"s first-in-class oligonucleotide-based Toll-like Receptor (TLR) inhibitors for use in inflammatory skin diseases such as psoriasis, cutaneous lupus, and dermatomyositis. This new two-year $700,000 grant is in addition to a $1.8 million grant awarded in 2008.
POZEN Inc. (NASDAQ: POZN) reported that AstraZeneca has made the decision to have POZEN file the New Drug Application (NDA) for PN 400 with the United States Food and Drug Administration (FDA). POZEN continues to target a mid-2009 NDA filing and expects to receive a milestone payment of $10 million when the NDA is formally accepted for submission by the FDA.
During a White House teleconference last week, Nancy-Ann DeParle, director of the White House Office on Health Reform said that reducing health care costs is "particularly important for the [black] community because on average, they spend a higher percentage of their income on health care costs, compared to their white counterparts," the Washington Informer reports. Nancy-Ann DeParle, director of the office, at a press conference last week said that reducing health care costs is "particularly important for the [black] community because on average, they spend a higher percentage of their income on health care costs, compared to their white counterparts." She added that blacks spend about 16.5% of their income on health care, while whites spend about 12%. In addition, blacks "continue to face disparities in terms of the (quality of care) they get," DeParle said. According to DeParle, blacks tend to visit hospitals that "provide lower-quality care." She added that higher health care costs are "especially troubling" to the black community because blacks "suffer from higher percentages of chronic diseases such as heart disease, kidney disease and diabetes, that are due in part to a lack of access to quality care."According to the Informer, $1 billion of the $787 billion stimulus package that President Obama signed in February will be allocated to prevention efforts and public health campaigns (Michaels, Washington Informer, 5/21).
"Stem cell research and regenerative medicine are in an extremely exciting phase right now. We are gaining knowledge very fast and many companies are being formed and are starting clinical trials in different areas," says Dr Jonas Frisçİn.
Most of the current obesity research is not proving helpful in finding solutions to the growing international epidemic, according to a Deakin University public health expert.
Autism Spectrum Therapies (AST), an agency providing behavior therapy and other autism services, now offers new summer programs for children of all ages and their parents. These fun, kid-friendly programs are designed to help children with autism disorders maintain their academic and communication skills over summer vacation and to develop new skills for the upcoming school year.
New research from the US suggests that people who drink from bottles made of polycarbonate plastic, such as that used to make hard-plastic
Workers in one of the largest PCT"s in the UK have been benefiting from a scheme that is part of the "improving working lives in the workplace" initiative. Since January 2009, training company, Ethos (Education, Training, Health and Online Service Ltd) have been working with staff across all disciplines within the trust including clinical and non-clinical staff on a programme of taster complementary therapy sessions.
New advice to help people with respiratory problems cope in a heatwave is published by the Department of Health.
Vaginal thrush (thrush) is a yeast infection caused by a type of fungus of the candida species, usually Candida albicans. It can affect all women, but is more common among women who are pregnant, those who have weakened immune systems, and women aged 30 to 50. Thrush is generally recurring - it comes back. The fungus, candida albicans, exists naturally in the vagina. As long as it does not multiply too much a woman will not notice it is there. However, if can sometimes multiply to such an extent that it causes swelling of the vagina and vulva.
Metabolic surgery, a new surgical approach to metabolic disease, may provide the key to curing diabetes in some patients. This data was presented at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress.
IBM (NYSE: IBM) announced it has been selected to help Ling Tung University build a smarter healthcare system to monitor the health of senior citizens in Taiwan anywhere, at anytime. The project is part of the university"s "Health-4U" program, which has been launched as response to the Senior U-Care Flagship Program initiated by the Department of Industrial Technology under Taiwan"s Ministry of Economic Affairs.
Republicans on the Senate Judiciary Committee delayed a confirmation vote on President Obama"s nominees for federal court positions until after the Memorial Day recess, Roll Call reports. David Hamilton, a district court judge in southern Indiana, is nominated for the 7th U.S. Circuit Court of Appeals, and Andre Davis is nominated for the 4th U.S. Circuit Court of Appeals (Brady, Roll Call, 5/21). Committee ranking member Jeff Sessions (R-Ala.) said, "Our members are concerned" about Hamilton, adding that Hamilton "has had a number of troubling rulings dealing with a series of prayers at the Indiana Legislature." Hamilton in 2005 ruled that prayers used to open the Legislature must be nonsectarian. Sessions said he also is concerned about Hamilton"s ruling to prohibit religious displays in public buildings. Committee Chair Patrick Leahy (D-Vt.) defended Hamilton"s record. Leahy said, "He is, after all, the son of a minister, and he believes very strongly in the constitutional separation of church and state" (Stern, Bloomberg/Philadelphia Inquirer, 5/22). Leahy added that Hamilton "ought to be commended rather than obstructed or delayed." Meanwhile, the committee is awaiting Obama"s nominee to replace Justice David Souter on the Supreme Court. The nomination could further complicate consideration of Hamilton and Davis, as it is expected to occupy the panel through the summer (Roll Call, 5/21).
Drinking on college campuses in the United States is a pervasive problem, leading to numerous problems. One study estimated that more than 500,000 college students suffered alcohol-related injuries in 2001. This study examined the "dose-response" effect of quantities and frequencies, finding that heavy drinkers with a sensation-seeking disposition had the greatest risk of alcohol-related injuries.
Someone who has a low level of response (LR) to alcohol, meaning relatively little reaction to alcohol, has a higher risk for developing alcohol-use disorders (AUDs). A study that examined the influence of LR in conjunction with other characteristics - like family history of AUDs and age of drinking onset - has found that LR is a unique risk factor for AUDs across adulthood and is not simply a reflection of a broader range of risk factors.
A researcher with Weill Cornell Medical College has developed a vaginal ring that releases microbicides and could prevent HIV and unplanned pregnancies, ANI/Times of India reports. Brij Saxena -- a professor of reproductive biology and endocrinology and lead author of a recent study on the ring in the journal AIDS -- said that laboratory testing showed the device would be effective at preventing HIV infection and pregnancy by releasing several types of nonhormonal agents and microbicides. He added that if proven successful in clinical trials, the device would allow women to effectively protect themselves from HIV and avoid pregnancy. According to Saxena, the ring releases antiretroviral drugs over a period of 28 days. He noted that the device potentially could serve as an alternative method to prevent other sexually transmitted infections. Jeffrey Laurence, co-author of the study and a physician at New York Presbyterian Hospital-Weill Cornell Medical Center, said, "No one has ever conquered a viral epidemic with treatment, so prevention is the most effective option." He added, "Ideally, an HIV vaccine is the most desirable method, but that is not foreseeable in the near future. The next best thing would be something that would prevent infection and put the power in the susceptible female partner"s control. That"s the potential a device such as this can offer" (ANI/Times of India, 5/20).
Medarex, Inc. (Nasdaq: MEDX) announced that the MDX-1100 Phase 2 proof-of-concept trial in patients with active rheumatoid arthritis (RA) receiving methotrexate successfully met its primary endpoint. The top-line results from the recently completed 70-patient multi-center, randomized, double-blind, placebo-controlled Phase 2 trial indicated that when compared to placebo, three times the number of patients treated with 10 mg/kg of MDX-1100 every two weeks achieved at least a 20% improvement in RA signs and symptoms at 12 weeks, the primary endpoint of the study, as measured by the American College of Rheumatology (ACR) 20 measurement of response. These results were statistically significant when compared with placebo (p=0.0024). The antibody combination with methotrexate was generally safe and well-tolerated. Full results from this Phase 2 trial are planned to be presented at a future scientific meeting.
"Trends in Child Health 1997-2006: Assessing Racial/Ethnic Disparities in Unmet Dental Care Needs," Joint Center for Political and Economic Studies: The issue brief examines disparities in the reporting of unmet dental care needs because of cost over the past 12 months among black, Hispanic and white children younger than age 18. The brief compares the unmet dental care needs among the racial/ethnic groups of children overall and among children of various racial/ethnic groups in families with similar sociodemographic characteristics, such as family type, poverty status and health insurance coverage. Hispanic children are the most likely to have dental care needs that are unmet because of cost, according to the brief. In addition, the brief analyzes several indicators of child health -- including low birthweight, health status, unmet dental care needs, ADHD/ADD diagnosis and asthma diagnosis -- to provide additional details of disparities in child health (Joint Center for Political and Economic Studies, May 2009).
A discovery made by researchers at McGill University and the affiliated Lady Davis Research Institute for Medical Research at Montreal"s Jewish General Hospital offers new hope for the early diagnosis and treatment of Alzheimer"s disease.
Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational product candidate, Acetavance(TM) (intravenous acetaminophen), for the treatment of acute pain and fever in adults and children. If approved, Acetavance would become the first new intravenous analgesic approved in the United States in more than 20 years and the only approved intravenous agent for the treatment of fever in the United States.
The latest special issue of Science in China Series C: Life Sciences focuses on the recent progress in the H5N1-related research field.
Results presented today at the 162nd American Psychiatric Association (APA) congress in San Francisco, CA, demonstrated the efficacy and tolerability of SEROQUEL® (quetiapine fumarate) for treating depressive episodes in bipolar disorder, including the difficult-to-treat bipolar II patient population.1,2 The data are from combined analyses of four large-scale clinical trials to examine SEROQUEL as a treatment for depressive episodes associated with bipolar I and II disorders. SEROQUEL and SEROQUEL XR™, a once-daily, extended-release formulation of SEROQUEL, is one of the most widely studied atypical antipsychotic in bipolar depression and the only agent approved as monotherapy to treat the spectrum of mood episodes associated with bipolar disorder.
Americans trying to eat healthier are looking to nutrition labels to help make better choices at the grocery store. But consumers who take those labels at face value may find they"re not eating as healthy as they think.
Women who are at risk for heart disease and who are also experiencing menopause symptoms now have an added re - a highly specialized clinic in the Division of Cardiology at the Cedars-Sinai Heart Institute. The Advanced Preventive Women"s Clinic at the Women"s Heart Center recently opened and is offering comprehensive cardiac risk assessments designed specifically for women who are in menopause. The clinic also offers menopausal patients state-of-the-art screenings, as well as personalized medicine therapies and counseling, including high-risk hormone counseling.
Researchers in Finland who tracked the health of over 1,000 men from middle age into old age found that being overweight and having high risk
People with diabetes who were prescribed the cholesterol-lowering drug fenofibrate reduced their risk of minor amputations by 36 per cent, according to new research.
There are many ways to deal with the pain of giving birth, but women and their obstetricians can always benefit from having another choice. A Cochrane review has concluded that women in labor should have the option of using transcutaneous electrical nerve stimulation (TENS) a non-drug method of pain management.
QIAGEN announced the launch of a novel product for extraction of free circulating fragments of tumor- and fetal-derived nucleic acids as well as viral nucleic acids in human blood. Scientists consider these DNA and RNA fragments to have great potential for the highly sensitive and non-invasive diagnosis of a wide range of diseases, including congenital disorders, malignancies such as colon and lung cancer, and infections. The new QIAamp Circulating Nucleic Acid Kit is expected to significantly facilitate the corresponding biomarker research and the introduction of novel molecular tests in prenatal diagnostics which can replace risky, invasive procedures such as amniocentesis.
There has been an alarming rise in new cases of the deadliest form of skin cancer in the UK, with binge tanning cited as a main reason, said a
UroToday.com - Angiogenesis is the process of new blood vessel formation in tumors, facilitating their growth. Endostatin is a cleavage product of collagen and is a potent inhibitor of endothelial cell proliferation and migration. Endostatin causes apoptosis in endothelial and tumor cells. Prostate cancer expresses angiogenic factors.
Funding from the Biotechnology and Biological Sciences Research Council (BBSRC) could lead to the development of new and better treatments for broken bones and other orthopaedic problems associated with ageing.
With support from a foundation that champions cutting-edge medical research, a biomedical engineer at UC Davis will start work this month on developing a new treatment for infants born with disorders that cause the sutures of their skulls to prematurely fuse together.
UroToday.com - Our first results of sentinel node mapping with intraoperative radioguidance in urological tumors are described in our abstract. We selected this movie to show the whole imaging procedure. In a patient with prostate cancer, the radiopharmaceutical is injected in 4 depots into the prostate. After tracer administration, planar lymphoscintigraphy is performed after 15 minutes and in 2 hours is followed by a SPECT/CT. After fusion of corresponding SPECT and CT slices, the two-dimensional fusion images show the location of the sentinel nodes.
Research undertaken at the Center for Applied Medical Research (CIMA) and the University Hospital of Navarra has shown that, in animal models, stem cells derived from bone marrow and adipose tissue enhance heart function after a cardiac attack. In concrete, bone marrow cells act on the damaged tissue, while fatty cells have the ability to transform themselves into both blood vessels and cardiac cells. The results obtained with rats are maintained over a long time period, explained biochemist Mr Manuel Mazo, principal researcher.
Scientists in Germany have discovered a gene that links the gum disease periodontitis and increased risk of coronorary heart disease (CHD) and
Approximately half of adults surveyed on water safety say they"ve had an experience where they nearly drowned in their lifetime, and one in four know someone who has drowned, according to an American Red Cross survey.
Researchers with the Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center will continue their unique work thanks to a second $1 million grant from the Komen organization.
Nigel Edwards, the director of policy at the NHS Confederation, said, "The surpluses generated by the NHS over the 2007-2008 financial year are a testament to sound financial planning and an awareness on the part of everyone in the service of the need to spend public money carefully.
I"m a Celebrity: Get Me out of Here! star David Van Day today (20 May) swapped jungle bugs and snakes for mugs and cakes to raise vital funds and awareness for people with dementia and their carers.
Although teen depression poses a widespread problem for which proven treatments exist, few depressed teens receive any care.
Relatives of a young person who dies suddenly should always be referred for cardiological and genetic examination in order to identify if they too are at risk of sudden death, a scientist told the annual conference of the European Society of Human Genetics. Dr. Christian van der Werf, a research fellow at the Department of Cardiogenetics, Academic Medical Centre, Amsterdam, The Netherlands said that, although his team"s research showed that inherited heart disease was present in over 30% of the families of sudden unexplained death (SUD) victims, the majority of such relatives were currently not being referred for examination.
Over the past few years, MIT engineers have successfully tested robotic devices to help stroke patients learn to control their arms and legs. Now, they"re building on that work to help children with cerebral palsy.
At a time when the drug industry is striving for patient-friendly delivery methods for new and existing drugs, the growing availability of innovative inhaler device designs is driving interest in pulmonary drug delivery technology and devices as an alternative to oral and parenteral routes of administration. While well-established for treating upper respiratory diseases such as asthma and COPD, companies competing in the inhaled drug delivery sector - major players such as GlaxoSmithKline, AstraZeneca and Boehringer Ingelheim as well as pure-play start-ups - continue to view delivery of systemic drugs via inhalation as a major opportunity.
Definiens, the number one Enterprise Image Intelligence® company, announced that Moffitt Cancer Center will utilize Definiens technology in the analysis of lung cancer CT images for the purpose of developing more accurate prognosis and prediction models for response to specific lung cancer therapies. Image features extracted with Definiens technology will be compared to disease outcomes, as well as gene expression data available through Total Cancer CareTM, Moffitt"s comprehensive approach to cancer that enables researchers and caregivers to identify and meet all the needs of a patient and their family during the patient"s lifetime and for future generations.
Journalists are invited to register for the 36th European Symposium on Calcified Tissue in Vienna, 23 - 27 May. Presentations offer state-of-the-art research on bone and mineralized tissue, as well as the diagnostis and treatment of metabolic bone disease.
Scientists at the Medical Research Council Laboratory of Molecular Biology uncover how an important cancer gene, BRCA1, works by increasing the accuracy with which broken DNA is repaired. Women who inherit a faulty version of the BRCA1 gene are at a higher risk of developing breast or ovarian cancer.
Viruses are molecular marauders, plundering cells for the res they
If we imagine our immune system to be a police force for our bodies, then previous work has suggested that the Lymph nodes would be the best candidate structures within the body to act as police stations - the regions in which the immune response is organised. However, a new paper - published in this week"s issue of PLoS Biology - suggests that lymph nodes are not essential in the mouse in marshalling T-cells (a main immune foot soldier) to respond to a breach of the skin barrier. This result is both surprising in itself, and suggests a novel function for the liver as an alternate site for T-cell activation.
TeleHealth Services, the nation"s leading provider of healthcare grade televisions and on-demand patient and staff interactive education solutions, has announced the implementation of its TIGR on-demand video education and entertainment system into Timpanogos Regional Hospital in Orem, Utah.
The 22nd Congress of the European College of Neuropsychopharmacology (ECNP) will be held from 12-16 September 2009 in Istanbul, Turkey.
There are several risk factors for the development of Alzheimer"s disease and vascular dementia. Based on an increasing number of studies linking these risk factors with Vitamin D deficiency, an article in the current issue of the Journal of Alzheimer"s Disease (May 2009) by William B. Grant, PhD of the Sunlight, Nutrition, and Health Research Center (SUNARC) suggests that further investigation of possible direct or indirect linkages between Vitamin D and these dementias is needed.
Ascenta Therapeutics announced that eleven presentations or publications on pre-clinical and clinical studies of AT-101, an oral, pan-Bcl-2 inhibitor, in several major tumor types will be made during the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting, May 29-June 2, in Orlando, Florida.
Mayo Clinic researchers are reporting positive results in early leukemia clinical trials using the chemical epigallocatechin gallate (EGCG), an active ingredient in green tea. The trial determined that patients with chronic lymphocytic leukemia (CLL) can tolerate the chemical fairly well when high doses are administered in capsule form and that lymphocyte count was reduced in one-third of participants. The findings appear today online in the Journal of Clinical Oncology.
Today sees the European launch of the first topical calcineurin inhibitor to be approved for the maintenance treatment of eczema to prevent flares and prolong flare-free intervals. PROTOPIC ointment (tacrolimus monohydrate) is already licensed to treat moderate and severe eczema (atopic dermatitis), often involving the treatment of flares as and when they occur.* It is now also approved for twice-weekly application to previously affected skin to prevent these exacerbations and prolong flare-free periods in PROTOPIC-responsive patients.ò Clinical studies have shown that this new approach brings significant benefits with over 40% of patients with moderate to severe eczema remaining flare-free for at least a year.1 Flares are known to place an enormous burden on patients. The International Study of Life with Atopic Eczema (ISOLATE) found that about 55% of these patients worried about the onset of their next exacerbation and that they spent on average over a third of the year (136 days) with their eczema in flare.2
It"s not just MPs who can make inappropriate claims for recompense or misunderstand the rules, warns the Medical and Dental Defence Union of Scotland (MDDUS).
A new analysis by AARP"s Public Policy
A study published in the June issue of Anesthesiology has shown that a drug metabolite of the opioid morphine may be a key factor in the paradoxical increased sensitivity to pain caused by chronic morphine use. For the first time, this metabolite (called morphine-6 glucuronide, or M6G) was shown to act independently of the pain receptors typically targeted during morphine administration.
Agendia, a world leader in molecular cancer diagnostics, today announced
Responding to Health Secretary Alan Johnson"s announcement of a review on the impact of the European Working Time Directive on doctors" training, Dr Andy Thornley, Chair of the BMA"s Junior Doctors Committee, said:
CircuLite®, Inc. will be participating at the 2009 American Society for Artificial Internal Organs (ASAIO) conference in conjunction with the 5th International Conference on Pediatric Mechanical Circulatory Support Systems & Pediatric Cardiopulmonary Perfusion (PEDS) held May 28 - 30, 2009 in Dallas, with a booth display featuring it"s Synergy® Pocket Circulatory Assist Device. Synergy is the first micro-pump designed for long-term, partial circulatory support to improve the quality of life for a broad range of chronic heart failure patients.
"The most lamentable and heart-breaking dimension of multilateralism" is the "absence of any serious focus on gender throughout" the United Nations system, Stephen Lewis, founder of AIDS-Free World, writes in a London Independent opinion piece. He adds, "I can cite chapter and verse, but let me start by telling you that whether it is poverty alleviation, or HIV and AIDS, or sexual violence and conflict, the whole panoply of discrimination visited on women around the world, particularly in developing countries, the U.N."s agencies and the Secretariat have been profoundly delinquent in their response."According to Lewis, the "struggle for gender equality has become the most important struggle on the planet; the continuing marginalization of 52% of the world"s population is simply unacceptable." He adds, "So we"re now engaged in an effort to create a new international agency for women, a fascinating undertaking that I hope will engage" governments. "Nothing approximates the possibility of finally having a vehicle that would give voice and res and support to the struggles of women around the world," Lewis writes, adding, "Everyone knows what"s happening in these areas about women"s vulnerability but there is never a consistent voice to bring it to the attention of the world community, to continue to hammer it home, to demand action from government." He concludes, "So the emergence and creation of a women"s agency I think would be a godsend internationally and would overcome the record of the United Nations on gender" (Lewis, Independent, 5/22).
UCB has announced that Vimpat® (lacosamide) C-V , a new antiepileptic drug (AED) is available in the U.S. as an add-on therapy for the treatment of partial-onset seizures in people with epilepsy who are 17 years and older. Vimpat® will be available in U.S. pharmacies by the first week of June 2009.
Babies of East Asian and South Asian descent are between two and three times more likely to be misclassified as underweight at birth when compared to their Canadian counterparts, according to a study led by St. Michael"s Hospital physician Dr. Joel Ray. Dr. Ray and a team of researchers, who developed the first-ever sex-specific birth weight curves for these ethnic groups, suggest the need to consider differences across ethnic groups to reduce parental stress and use of health-care res associated with labelling an infant as underweight, or "small for gestational age" at birth.
UCB today announced that Vimpat® (lacosamide) C-V, a new antiepileptic drug (AED) is available in the U.S. as an add-on therapy for the treatment of partial-onset seizures in people with epilepsy who are 17 years and older. Vimpat® will be available in U.S. pharmacies by the first week of June 2009.
Researchers at the University of Maryland School of Medicine have found that an approved drug for treating rheumatoid arthritis reduces severe illness and death in mice exposed to the Influenza A virus. Their findings suggest that tempering the response of the body"s immune system to influenza infection may alleviate some of the more severe symptoms and even reduce mortality from this virus.
Novel chemotherapy and biological agents for metastatic colorectal cancer, combined with surgical advances in liver resection, have resulted in a dramatic increase in survival for patients with advanced disease, according to researchers at The University of Texas M. D. Anderson Cancer Center.
Statins, a commonly prescribed class of drugs used by millions worldwide to effectively lower blood cholesterol levels, may actually have a negative impact in Multiple Sclerosis (MS) patients treated with high daily dosages.
Ontario has invested millions of dollars into the healthcare system in response to a serious doctor shortage. But despite improvements in primary care, a study out of the Institute for Clinical Evaluative Sciences (ICES) has found Ontario"s chronically sick and poor are the least likely to benefit from the investments.
A Senior Lecturer from Canterbury Christ Church University has been awarded Fellowship of the Institute of Healthcare Management (IHM) at a ceremony on Thursday 14th May.
- 0 confirmed cases in Wales.
Merrill Egorin, M.D., professor of medicine and pharmacology at the University of Pittsburgh Cancer Institute (UPCI), has received the 2009 American Society of Clinical Oncology (ASCO) Translational Research Professorship for his work in improving cancer treatments and supporting the next generation of researchers.
The incidence of cardiovascular disease is rising due to factors such as ageing, obesity, smoking and other cardiac ailments. Each year cardiovascular diseases cause over 4.3 million deaths, accounting for 48 per cent of all mortalities in Europe.
Researchers at the Mayo Clinic set out to determine whether the flu vaccine
Researchers at Roswell Park Cancer Institute (RPCI) in Buffalo, New York, are strongly advocating a national discussion about the need to vaccinate both young men and women against HPV 16 to prevent head & neck cancers. The call comes amid growing evidence that certain cancers of the head and neck are strongly linked to HPV 16, a specific strain of the human papillomavirus (HPV) that is one of the most common sexually transmitted diseases in the United States. It is estimated that approximately 70% of Americans, both men and women, will be infected with HPV at some point in their lives.
Surfing under the influence of drugs or alcohol are two of the prime dangers facing surfing enthusiasts, according to information presented today at the 56th Annual Meeting of the American College of Sports Medicine in Seattle. Other factors include wave height, board length and interactions among surfers.
Stress levels and cultural considerations affect how much and for what reasons college students exercise, according to research presented at the American College of Sports Medicine"s 56th Annual Meeting in Seattle.
Triage technology comes with a Star Trek twist, at the U.S. Department of Homeland Security"s Science & Technology Directorate (DHS S&T).
In the second call for proposals, projects focus on either the development of new technologies or on the interface between biomedical research and genomics. The Swiss National Science Foundation (SNSF) approved six RTD-projects today. They will engage a total of 47 research groups from both Swiss Federal Institutes of Technology (ETH Zurich und EPF Lausanne), as well as from the Universities of Basel, Lausanne, Geneva and Zurich. The Friedrich-Miescher Institute of the Novartis Research Foundation is also represented as the only privately financed institution. Eight groups belong simultaneously to one of the above-mentioned universities and to the Swiss Institute for Bioinformatics.
Z-Cube Srl, the corporate venture arm of Zambon Company SpA, and Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, announced today that they have entered into a license agreement for Z-Cube to develop and commercialize an innovative nanotechnology drug delivery system for the treatment of pain. The technology was invented by Professor Elka Touitou from the Department of Pharmaceutics, Faculty of Medicine, at the Hebrew University of Jerusalem.
When Chicago Blackhawk"s leading scorer Martin Havlat returned to the ice for game four of the Western Conference Final after sustaining a concussion only two days earlier, questions were raised surrounding his swift return. According to a new study by St. Michael"s Hospital neurosurgeon Dr. Michael Cusimano, similar questions were raised by 25% of minor league hockey players who did not know if an athlete with symptoms of a concussion should continue to play hockey. Nearly a majority of these players were also unable to identify a concussion or its related symptoms.
Celleron Therapeutics Ltd, the Oxford UK based specialist in the development of individually targeted cancer medicines, has secured exclusive rights to AstraZeneca plc"s lead histone deacetylase (HDAC) inhibitor (AZD 9468), for global development in conjunction with its proprietary "CancerNav" predictive biomarker platform. "CancerNav" specifically identifies those tumours which are most likely to respond to an individual cancer drug, thereby enabling a highly focussed clinical development and commercialisation programme, based on a closely linked diagnostic and therapeutic "personalised medicine" approach.